This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Slegtenhorst-Eegdeman, K. E. Articles by Themmen, A. P. N. Search for Related Content PubMed PubMed Citation Articles by Slegtenhorst-Eegdeman, K. E. Articles by Themmen, A. P. N.

Macroorchidism in FMR1 Knockout Mice Is Caused by Increased Sertoli Cell Proliferation during Testicular Development¹

Departments of Endocrinology and Reproduction and Clinical Genetics (C.E.B., B.A.O.), Faculty of Health and Health Sciences, Erasmus University Rotterdam, Rotterdam; and the Department of Cell Biology, Medical School, Utrecht University (D.G.d.R., H.J.G.v.d.K.), Utrecht, The Netherlands

Address all correspondence and requests for reprints to: Dr. Axel P. N. Themmen, Department of Endocrinology and Reproduction, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. E-mail: themmen{at}endov.fgg.eur.nl

The fragile X syndrome is the most frequent hereditary form of mental retardation. This X-linked disorder is, in most cases, caused by an unstable and expanding trinucleotide CGG repeat located in the 5'-untranslated region of the gene involved, the fragile X mental retardation 1 (FMR1) gene. Expansion of the CGG repeat to a length of more than 200 trinucleotides results in silencing of the FMR1 gene promoter and, thus, in an inactive gene.

The clinical features of male fragile X patients include mental retardation, autistiform behavior, and characteristic facial features. In addition, macroorchidism is observed. To study the role of Sertoli cell proliferation and FSH signal transduction in the occurrence of macroorchidism in fragile X males, we made use of an animal model for the fragile X syndrome, an Fmr1 knockout mouse.

The results indicate that in male Fmr1 knockout mice, the rate of Sertoli cell proliferation is increased from embryonic day 12 to 15 days postnatally. The onset and length of the period of Sertoli cell proliferation were not changed compared with those in the control males. Serum levels of FSH, FSH receptor messenger RNA expression, and short term effects of FSH on Sertoli cell function, as measured by down-regulation of FSH receptor messenger RNA, were not changed.

We conclude that macroorchidism in Fmr1 knockout male mice is caused by an increased rate of Sertoli cell proliferation. This increase does not appear to be the result of a major change in FSH signal transduction in Fmr1 knockout mice.

This article has been cited by other articles:

				K. J Teerds, E. Rijntjes, M. B Veldhuizen-Tsoerkan, F. F G Rommerts, and M. de Boer-Brouwer The development of rat Leydig cell progenitors in vitro: how essential is luteinising hormone? J. Endocrinol., September 1, 2007; 194(3): 579 - 593. [Abstract] [Full Text] [PDF]

				P. I. Sadate-Ngatchou, D. J. Pouchnik, and M. D. Griswold Identification of Testosterone-Regulated Genes in Testes of Hypogonadal Mice Using Oligonucleotide Microarray Mol. Endocrinol., February 1, 2004; 18(2): 422 - 433. [Abstract] [Full Text] [PDF]

				M. L. Meistrich and G. Shetty Inhibition of Spermatogonial Differentiation by Testosterone J Androl, March 1, 2003; 24(2): 135 - 148. [Full Text] [PDF]

				D.D. Lunstra, T.H. Wise, and J.J. Ford Sertoli Cells in the Boar Testis: Changes During Development and Compensatory Hypertrophy after Hemicastration at Different Ages Biol Reprod, January 1, 2003; 68(1): 140 - 150. [Abstract] [Full Text] [PDF]

				A. L. L. Durlinger, M. J. G. Gruijters, P. Kramer, B. Karels, T. R. Kumar, M. M. Matzuk, U. M. Rose, F. H. de Jong, J. Th. J. Uilenbroek, J. A. Grootegoed, et al. Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary Endocrinology, November 1, 2001; 142(11): 4891 - 4899. [Abstract] [Full Text] [PDF]

				S. A. Irwin, R. Galvez, and W. T. Greenough Dendritic Spine Structural Anomalies in Fragile-X Mental Retardation Syndrome Cereb Cortex, October 1, 2000; 10(10): 1038 - 1044. [Abstract] [Full Text] [PDF]

				A. M. Peier, K. L. McIlwain, A. Kenneson, S. T. Warren, R. Paylor, and D. L. Nelson (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features Hum. Mol. Genet., May 1, 2000; 9(8): 1145 - 1159. [Abstract] [Full Text] [PDF]

				A. L. L. Durlinger, P. Kramer, B. Karels, F. H. de Jong, J. Th. J. Uilenbroek, J. A. Grootegoed, and A. P. N. Themmen Control of Primordial Follicle Recruitment by Anti-Mullerian Hormone in the Mouse Ovary Endocrinology, December 1, 1999; 140(12): 5789 - 5796. [Abstract] [Full Text]

				T. L. Beumer, H. Kiyokawa, H. L. Roepers-Gajadien, L. A. C. van den Bos, T. M. T. W. Lock, I. S. Gademan, D. H. Rutgers, A. Koff, and D. G. de Rooij Regulatory Role of p27kip1 in the Mouse and Human Testis Endocrinology, April 1, 1999; 140(4): 1834 - 1840. [Abstract] [Full Text]